carnitine has been researched along with Anti-MuSK Myasthenia Gravis in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The mechanism(s) of immune checkpoint inhibitor (ICI)-induced myasthenia gravis (MG), an immune-related adverse event (irAE) that is fatal and limits subsequent ICI use, remain unexplored." | 1.72 | Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis. ( Chen, L; Gao, W; Gong, Q; Guo, R; Jin, S; Li, J; Liu, X; Shao, YW; Shen, L; Sun, C; Wang, Q; Wang, W; Wang, Z; Wu, L; Xu, J; Yin, JC; Zhang, W, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, W | 3 |
| Wu, L | 3 |
| Jin, S | 3 |
| Li, J | 3 |
| Liu, X | 3 |
| Xu, J | 3 |
| Zhang, W | 3 |
| Gong, Q | 3 |
| Sun, C | 3 |
| Wang, W | 3 |
| Wang, Z | 3 |
| Shao, YW | 3 |
| Yin, JC | 3 |
| Shen, L | 3 |
| Chen, L | 3 |
| Wang, Q | 3 |
| Guo, R | 3 |
| Bazzato, G | 2 |
| Coli, U | 1 |
| Landini, S | 1 |
| Mezzina, C | 2 |
| Ciman, M | 2 |
| Kaeser, HE | 1 |
| Clair, F | 1 |
| Caillat, S | 1 |
| Soufir, JC | 1 |
| Lafforgue, B | 1 |
| Drüeke, T | 1 |
| Saïd, G | 1 |
| Buxton, PH | 1 |
| Guarnieri, G | 1 |
2 reviews available for carnitine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Drug-induced myasthenic syndromes.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Autoimmune Diseas | 1984 |
Pathology of muscle.
Topics: Adult; Carnitine; Carnitine O-Palmitoyltransferase; Child; Child, Preschool; Denervation; Female; Gl | 1980 |
4 other studies available for carnitine and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis.
Topics: Carnitine; Humans; Immune Checkpoint Inhibitors; Myasthenia Gravis; Solute Carrier Family 22 Member | 2022 |
Myasthenia-like syndrome after D,L- but not L-carnitine.
Topics: Carnitine; Humans; Isomerism; Myasthenia Gravis | 1981 |
[Myasthenic syndrome induced by D,L-carnitine in a chronic hemodialysis patient].
Topics: Carnitine; Humans; Male; Middle Aged; Myasthenia Gravis; Renal Dialysis | 1984 |
Myasthenia-like syndrome associated with carnitine in patients on long-term haemodialysis.
Topics: Carnitine; Humans; Myasthenia Gravis; Renal Dialysis | 1979 |